| Research progress of Wnt/β-catenin signaling pathway regulating ocular pathological angiogenesis |
| Received:May 22, 2022 Revised:July 28, 2022 Click here to download the full text |
| Citation of this paper:WU Xin-yuan,YUAN Yuan-zhi.Research progress of Wnt/β-catenin signaling pathway regulating ocular pathological angiogenesis[J].Chinese Journal of Clinical Medicine,2023,30(6):1067-1073 |
| Hits: 343 |
| Download times: 169 |
|
| Abstract:Ocular pathological neovascularization diseases can significantly impair patients' visual acuity. At present, intraocular injection of anti-vascular endothelial growth factor (anti-VEGF) drugs is widely used as the first-line treatment, but there are limitations such as poor response and potential adverse reactions. Wnt/β-catenin signaling pathway has the function of promoting embryonic development and maintaining tissue homeostasis, and is widely expressed in tissues in vivo. When the Wnt/β-catenin signaling pathway is abnormally activated, the expression of downstream gene products can upregulate cytokines like hypoxia-inducible factor-1α (HIF-1α), and then promote pathological neovascularization in the eye. The application of Wnt inhibitors can delay the progression of pathological angiogenesis in the eye. The study of Wnt/β-catenin signaling pathway and pathological mechanism or ocular angiogenesis provides new potential targets for the treatment of ocular pathologic neovascularization diseases. |
| keywords:neovascularization age-related macular degeneration Wnt/β-catenin signaling pathway hypoxia-inducible factors-1α Wnt inhibitors |
| HTML View Full Text View/Add Comment Download reader |
|
|
|